In this study, we found that treatment with DHM or P2X7 receptor shRNA relieves neuropathic pain and depressive behaviors in rats with comorbid DNP and MDD and counteracts their elevated P2X7 receptor expression levels. Here, P2RX7 is linked to major depressive disorder.